Telerehabilitation in Alzheimer's Disease
NCT: NCT07722169 · NOT_YET_RECRUITING
Brief Summary
Telemedicine has developed rapidly during the COVID-19 pandemic and is now integrated into the clinical practice of many hospitals. Telemedicine offers many advantages, and even after the end of the pandemic, many patients still choose to undergo healthcare visits remotely. However, the rapid expansion of telemedicine may be associated with the risk of providing patients with unvalidated and uncontrolled telehealth solutions, potentially negatively impacting their health. In this study, the researchers aim to investigate the effectiveness of remote cognitive training in patients with mild-to-moderate Alzheimer's disease (AD) using tablets equipped with virtual reality-based cognitive exercises. The investigators also aim to evaluate the impact of online supervision of cognitive training by a neuropsychologist and to compare the costs and burden of home-based versus hospital-based cognitive training in patients with AD. This project will define the optimal modalities for cognitive telerehabilitation to ensure validated protocols for the continuity of care in AD.
Frequently Asked Questions
What is Telerehabilitation in Alzheimer's Disease?
Telerehabilitation in Alzheimer's Disease is a clinical trial registered under NCT07722169. Current status: NOT_YET_RECRUITING.
What is the status of NCT07722169?
The current status of NCT07722169 (Telerehabilitation in Alzheimer's Disease) is: NOT_YET_RECRUITING.
When did Telerehabilitation in Alzheimer's Disease start?
Telerehabilitation in Alzheimer's Disease started on 2026-10.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.